Loading
Loading…
Loading…
Ref. No.
Eligibility, documents, scope and key termsEligibility, required documents, scope of work and key terms of this tender, in one click.
Tender Value
Refer Docs
EMD Value
Exempted
Closing Date
30 Jul 2025, 11:00 amClosed
Eligibility, documents, scope and key termsEligibility, required documents, scope of work and key terms of this tender, in one click.
Common Cold Tab cetirizine 5 minus 10 mg plus paracetamol 500 mg plus pseudoephedrine
Meloxicam 15 mg tab
Piroxicam Tab 20 mg
Sitagliptin 50 mg Plus Metformin 500 mg tab
Inj Amoxycillin 50 mg plus Clavulanic Acid 100 mg comma 600 mg Vial
8089265
GEM/2025/B/6452680
Two Packet Bid
Common Cold Tab cetirizine 5 minus 10 mg plus
15 days
BANDIPORA
Total value wise evaluation
BOQ
4 documents required · 4 mandatory
2 yrs
50%
Exempted
30 Jul 2025
15 Jul 2025
30 Jul 2025
Common Cold Tab cetirizine 5 minus 10 mg plus paracetamol 500 mg plus pseudoephedrine
Meloxicam 15 mg tab
Piroxicam Tab 20 mg
Sitagliptin 50 mg Plus Metformin 500 mg tab
Inj Amoxycillin 50 mg plus Clavulanic Acid 100 mg comma 600 mg Vial
Common cold Tab (Cetirizine 5-10 mg+ Paracetamol 500 mg + Pseudoephedrine
Meloxicam 15 mg Tab
Piroxicam Tab 20 mg
Sitagliptin 50mg + Metformin 500 mg Tab
Inj Amoxycillin 50 mg + Clavulanic Acid 100 mg
600 mg Vial Bid Number : GEM/2025/B/6452680 Dated : 15-07-2025 Bid Document 1/8
Tap a document below to read it instantly. You can also download everything as a ZIP if you prefer.
bid_8089265.pdf
GEM_BID
list-of-categories-where-trials-are-allowed_1712126171.pdf
OTHER
gtc.pdf
OTHER
atc_2025_2025-07-15-10-16-37_e68c76dc3397f8112b3f4ff87501b605.pdf
BOQ
boq_item_sample_file_2025-07-15-10-16-37_4cd0b8dd0fdff174dbd4246eff740ef5.csv.pdf
BOQ
Download all tender documents and submit your bid
Disclaimer: TenderKart has made every reasonable effort to ensure that the information on this page is accurate and authentic, however it cannot be held liable for any third-party claims or losses or any damages. TenderKart makes no warranty, expressed or implied, as to the results obtained from the use of this information. If you notice any error or omission, please let us know at .